New reagents added to the CLC800 and CLC1500 clinical analyzers

Carolina Liquid Chemistries Corp. (CLC) has recently added three moderately complex reagents to their already extensive menu of tests for the CLC800 and the CLC1600 clinical chemistry analyzers.

The CLC800 is Carolina Liquid Chemistries’ cost-effective floor analyzer for small to mid-sized labs, while the CLC1600 is CLC’s powerful high-volume chemistry analyzer for mid to large sized labs.

Both analyzers already test 43 CLIA categorized reagents, but will now offer moderately complex APO A1 for the quantitative determination of human Apolipoprotein A1, APO B for the quantitative determination of human Apolipoprotein B, and RF for the quantitative determination of human rheumatoid factor to their menu.

Each test can aid in determining numerous health problems. For example, numerous studies have indicated that Apolipoprotein A1 may be a useful tool in the assessment of coronary heart disease risk. Patients with coronary disease consistently have lower levels of Apo AI.

Apo B measurements are useful in the diagnosis of atherosclerosis. Numerous studies have indicated that apolipoprotein B may be useful in assessing coronary heart disease risk. Patients with coronary disease consistently have higher levels of Apo B than control values.

Rheumatoid factor has been measured using a variety of methods, including agglutination, latex fixation, nephelometric, and enzyme-linked immunoabsorbent assay. The CLC marketed product uses an immunoturbidimetric assay format on a clinical chemistry analyzer.

For more information regarding the CLC800, the CLC1600, or Carolina Liquid Chemistries’ list of CLIA categorized reagents visit: https://www.carolinachemistries.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Carolina Liquid Chemistries Corp.. (2018, August 23). New reagents added to the CLC800 and CLC1500 clinical analyzers. News-Medical. Retrieved on December 22, 2024 from https://www.news-medical.net/news/20180823/New-reagents-added-to-the-CLC800-and-CLC1500-clinical-analyzers.aspx.

  • MLA

    Carolina Liquid Chemistries Corp.. "New reagents added to the CLC800 and CLC1500 clinical analyzers". News-Medical. 22 December 2024. <https://www.news-medical.net/news/20180823/New-reagents-added-to-the-CLC800-and-CLC1500-clinical-analyzers.aspx>.

  • Chicago

    Carolina Liquid Chemistries Corp.. "New reagents added to the CLC800 and CLC1500 clinical analyzers". News-Medical. https://www.news-medical.net/news/20180823/New-reagents-added-to-the-CLC800-and-CLC1500-clinical-analyzers.aspx. (accessed December 22, 2024).

  • Harvard

    Carolina Liquid Chemistries Corp.. 2018. New reagents added to the CLC800 and CLC1500 clinical analyzers. News-Medical, viewed 22 December 2024, https://www.news-medical.net/news/20180823/New-reagents-added-to-the-CLC800-and-CLC1500-clinical-analyzers.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
First EUA point-of-care (POC/Waived/Fingerstick) COVID-19 antibody test now available from Carolina Liquid Chemistries.